Brief: Arvinas Provides Update On Collaboration With Pfizer
17/09/2025 22:21
Sept 17 (Reuters) - Arvinas Inc ARVN.O: ARVINAS PROVIDES UPDATE ON COLLABORATION WITH PFIZER AND ANNOUNCES FURTHER ACTIONS TO SUPPORT VALUE CREATION ARVINAS INC - AUTHORIZES $100 MILLION STOCK REPURCHASE PROGRAM ARVINAS INC - CO AND PFIZER TO OUT-LICENSE VEPDEGESTRANT ARVINAS INC - REAFFIRMS CASH RUNWAY THROUGH 2028 ARVINAS INC - TO REDUCE WORKFORCE BY 15% ARVINAS INC: MOST SIGNIFICANT REDUCTIONS BEING ROLES RELATED TO VEPDEGESTRANT COMMERCIALIZATION ARVINAS INC: FURTHER LIMITING ADDITIONAL EXPENDITURES ON VEPDEGESTRANT PROGRAM Source text: ID:nGNX6HYLqs Further company coverage: ARVN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arvinas
See all newsBrief: Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Arvinas Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Arvinas - Pfizer, And Rigel Receive Hart-Scott-Rodino Clearance For License Agreement On June 11, 2026
Brief: Arvinas - Announces Re-Prioritization Of Portfolio Following Strategic Review - SEC Filing
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology